Evidence map›Paper›PMID 10655503›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes.

R E Ellsworth, D C Jamison, J W Touchman, S L Chissoe, V V Braden Maduro, G G Bouffard, N L Dietrich, S M Beckstrom-Sternberg, L M Iyer, L A Weintraub and 20 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Lung and Gut Microbiota Changes Associated withInternational journal of molecular sciences · 2021
    Article
  6. Fish-Ing for Enhancers in the Heart.International journal of molecular sciences · 2021
    Review
  7. Cystic Fibrosis Polymorphic Variants in a Russian Population.Pharmacogenomics and personalized medicine · 2020
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Association between divergence and interspersed repeats in mammalian noncoding genomic DNA.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 3 institutions in 1 country.

R E EllsworthGenome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
D C Jamison
J W Touchman
S L Chissoe
V V Braden Maduro
G G Bouffard
N L Dietrich
S M Beckstrom-Sternberg
L M Iyer
L A Weintraub
M Cotton
L Courtney
J Edwards
R Maupin
P Ozersky
T Rohlfing
P Wohldmann
T Miner
K Kemp
J Kramer
I Korf
K Pepin
L Antonacci-Fulton
R S Fulton
P Minx
L W Hillier
R K Wilson
R H Waterston
W Miller
E D Green
National Human Genome Research Institute · USNational Institutes of Health · USPennsylvania State University · US

Funding

SOFTWARE FOR ANALYZING BIOSEQUENCE DATAR01LM005110 · NLM · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI MILLER, WEBB COLBY · 1989 to 1999
–
NLM NIH HHS LM05110
6 · The paper itself

Abstract

The identification of the cystic fibrosis transmembrane conductance regulator gene (CFTR) in 1989 represents a landmark accomplishment in human genetics. Since that time, there have been numerous advances in elucidating the function of the encoded protein and the physiological basis of cystic fibrosis. However, numerous areas of cystic fibrosis biology require additional investigation, some of which would be facilitated by information about the long-range sequence context of the CFTR gene. For example, the latter might provide clues about the sequence elements responsible for the temporal and spatial regulation of CFTR expression. We thus sought to establish the sequence of the chromosomal segments encompassing the human CFTR and mouse Cftr genes, with the hope of identifying conserved regions of biologic interest by sequence comparison. Bacterial clone-based physical maps of the relevant human and mouse genomic regions were constructed, and minimally overlapping sets of clones were selected and sequenced, eventually yielding approximately 1.6 Mb and approximately 358 kb of contiguous human and mouse sequence, respectively. These efforts have produced the complete sequence of the approximately 189-kb and approximately 152-kb segments containing the human CFTR and mouse Cftr genes, respectively, as well as significant amounts of flanking DNA. Analyses of the resulting data provide insights about the organization of the CFTR/Cftr genes and potential sequence elements regulating their expression. Furthermore, the generated sequence reveals the precise architecture of genes residing near CFTR/Cftr, including one known gene (WNT2/Wnt2) and two previously unknown genes that immediately flank CFTR/Cftr.

Indexed as

GenesAnimalsCystic Fibrosis Transmembrane Conductance RegulatorHumansMiceMice, Inbred C57BLMolecular Sequence DataRegulatory Sequences, Nucleic AcidSequence AlignmentSequence Homology, Nucleic AcidSpecies SpecificityCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID10655503
PMCPMC15558
OpenAlexW2153928404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.